Precision Therapeutics announced that its Skyline Medical division, producer of the FDA-approved and CE-marked STREAMWAY System for automated, direct-to-drain medical fluid disposal, has received an order from its Australian distributor for three STREAMWAY system units to be placed in a “center of excellence” in an emerging orthopedic department at Wangaratta Hospital in Victoria, Australia.
Image: Precision Therapeutics’ Skyline Medical to supply three new STREAMWAY Systems at Wangaratta Hospital in Victoria. Photo: Courtesy of 1662222/Pixabay.
This installation will demonstrate the system’s innovative properties, functionality and cost effectiveness, especially for high volume procedures. The three units are a significant addition to Skyline’s presence in Australia and are placed in conjunction with its Australian distributor, Device Technologies, AU.
“We are particularly pleased to be introducing the STREAMWAY system to the Victoria market, as it represents Australia’s second-most densely-populated region. More importantly, the Wangaratta Hospital will serve as a center of excellence through which Device Technologies can effectively demonstrate the system to potential customers in a real-world application,” commented Dr. Carl Schwartz, chief executive officer of Precision Therapeutics. “We continue to be laser focused on expanding our world-wide market share and believe that this center will provide the opportunity to demonstrate the value, both clinical and financial of our industry leading, innovative direct-to-drain medical waste disposal systems, preventing unnecessary human intervention with potentially harmful waste fluids while controlling the spread of infection. Our inclusion in the Wangaratta Hospital likely will add to the confidence of the Australia medical device market in the STREAMWAY System.”
According to Goldstein Research, approximately 80 percent of all medical devices used in the Australian market come from outside the country. Analysts forecast the Australia medical device market size will reach USD 4.56 billion by 2025, at a CAGR of 10 percent over the forecast years.
Source: Company Press Release